These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 11590169
1. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. J Biol Chem; 2001 Dec 14; 276(50):46707-13. PubMed ID: 11590169 [Abstract] [Full Text] [Related]
2. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. J Cell Sci; 2002 Aug 01; 115(Pt 15):3193-206. PubMed ID: 12118074 [Abstract] [Full Text] [Related]
6. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fändrich F. J Biol Chem; 2005 Jan 28; 280(4):2644-52. PubMed ID: 15546867 [Abstract] [Full Text] [Related]
7. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, Cui Z, Thannickal VJ. J Biol Chem; 2004 Jan 09; 279(2):1359-67. PubMed ID: 14576166 [Abstract] [Full Text] [Related]
12. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. Miettinen PJ, Ebner R, Lopez AR, Derynck R. J Cell Biol; 1994 Dec 09; 127(6 Pt 2):2021-36. PubMed ID: 7806579 [Abstract] [Full Text] [Related]
13. Specific beta1 integrin site selectively regulates Akt/protein kinase B signaling via local activation of protein phosphatase 2A. Pankov R, Cukierman E, Clark K, Matsumoto K, Hahn C, Poulin B, Yamada KM. J Biol Chem; 2003 May 16; 278(20):18671-81. PubMed ID: 12637511 [Abstract] [Full Text] [Related]
14. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA. Mol Pharmacol; 2002 Jul 16; 62(1):58-64. PubMed ID: 12065755 [Abstract] [Full Text] [Related]
16. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M. Mol Biol Cell; 2003 Feb 16; 14(2):529-44. PubMed ID: 12589052 [Abstract] [Full Text] [Related]
17. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J, Dai C, Liu Y. J Am Soc Nephrol; 2005 Jan 16; 16(1):68-78. PubMed ID: 15537870 [Abstract] [Full Text] [Related]